Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation (2007)
- Authors:
- USP affiliated authors: COVAS, DIMAS TADEU - FMRP ; VOLTARELLI, JULIO CESAR - FMRP ; CASTRO, FABÍOLA ATTIÉ DE - FCFRP
- Unidades: FMRP; FCFRP
- Subjects: DIABETES MELLITUS; CÉLULAS-TRONCO (TRANSPLANTE)
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstract
- Conference titles: International Congress of Pharmaceutical Sciences (CIFARP)
-
ABNT
OLIVEIRA, Gislane Lelis Vilela et al. Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation. 2007, Anais.. São Paulo: ABCF, 2007. . Acesso em: 28 dez. 2025. -
APA
Oliveira, G. L. V., Malmegrim, K., Ferreira, A., Gasparotto, E., Kashima, S., Covas, D. T., et al. (2007). Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation. In Abstract. São Paulo: ABCF. -
NLM
Oliveira GLV, Malmegrim K, Ferreira A, Gasparotto E, Kashima S, Covas DT, Voltarelli JC, Castro FA de. Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation. Abstract. 2007 ;[citado 2025 dez. 28 ] -
Vancouver
Oliveira GLV, Malmegrim K, Ferreira A, Gasparotto E, Kashima S, Covas DT, Voltarelli JC, Castro FA de. Fas and fasl overexpression in type 1 diabetes patients after autologous hematopoietic stem cell transplantation. Abstract. 2007 ;[citado 2025 dez. 28 ] - Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation
- Downregulated expression of the bcl-'x IND.L'and mcl-1 antiapoptotic genes in type 1 diabetes patients after autologous hematopoietic stem cell transplantation
- Immunological effects of interferon-alpha on chronic myelogenous Leukemia
- Immunological follow-up of patients with chronic myelogenous leukemia treated with 'alfa'-IFN
- Immunotherapy of hematological neoplasms
- Immunological effects of donor lymphocyte infusion in patients with chronic myelogenous leukemia relapsing after allogenic bone marrow transplantation
- FAS and FASL expression on chronic myelogenous leukemia: a better understanding to disease progress
- Efeito do interferon-'alfa' na expressão dos antígenos Bcl-2, FAS e FASL na leucemia mielóide crônica
- Immunological follow-up of patients with chronic myelogenous leukemia treated with alpha-interferon
- Alterações imunológicas associadas ao uso do interferon-alfa na leucemia mielóide crônica
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
